China’s Pharma Industry is Booming with Talents and Startups. What Makes All the Rage?
China’s pharmaceutical market has become a global hotspot for investment in recent years. The diverse array of patients and increasing medical needs attract overseas companies, and China has also been sharpening local R&D power to compete with the global market.
GeneOnline attempts to look into the fast-paced market and analyzes China’s biopharma trends and development.
GO Prime with only $1.49 now
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23